For biotech companies, generative AI can improve the pace of innovation and improve efficiencies while providing better guardrails for privacy, security and compliance.
For biotech companies, generative AI can improve the pace of innovation and improve efficiencies while providing better guardrails for privacy, security and compliance. Generative models trained on biotech content can be augmented with specific private project or company content, automated to carry out validation checks to ensure content compliance (such as not including any personally identifiable information), and verified against specified checklists. - Amrit Jassal, Egnyte